Come up with a name for your new list and we'll add to it:
ChondroNest raised a round of funding on July 25, 2016. Investors include
Swiss Commission of Technology and Innovation.
ChondroNest is a composition of modified biopolymers from the extra cellular matrix designed to reconstruct cartilage. The technology licensed by ChondroNest is designed for the in vivo reconstruction…